Birchview Capital’s Array Biopharma Inc ARRY Stock Holding History

Birchview Capital’s Portfolio ARRY Stock Details ARRY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-168,000	Closed	-$7.78M	–	55
2019 Q2	$7.78M	Hold	168,000	–	–	4.73%	3
2019 Q1	$4.1M	Hold	168,000	–	–	2.57%	5
2018 Q4	$2.39M	Buy	168,000 +40,000	+31%	+$607K	2.26%	5
2018 Q3	$1.95M	Hold	128,000	–	–	1.26%	6
2018 Q2	$2.15M	Buy	128,000 +16,000	+14%	+$255K	1.46%	6
2018 Q1	$1.83M	Buy	112,000 +92,000	+460%	+$1.47M	1.2%	8
2017 Q4	$256K	Buy	+20,000	New	+$227K	0.15%	33

Other funds holding ARRY

ASN

Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Birchview Capital's ARRY Position: Q3 2019 in Review

Birchview Capital sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 168,000 shares — an estimated $7.78M sold.

Birchview Capital first reported a position in ARRY in Q4 2017 and held it in 7 quarters. The position peaked at $7.78M in Q2 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

Birchview Capital reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
Birchview Capital sold 168,000 Array Biopharma Inc shares in Q3 2019, an estimated $7.78M.
Birchview Capital first reported a position in Array Biopharma Inc in Q4 2017 and held it in 7 quarters.
Birchview Capital's Array Biopharma Inc position peaked at $7.78M in Q2 2019.
1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on Birchview Capital's 13F filing for Q3 2019, filed 12 Nov 2019.